SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-24-003748
Filing Date
2024-05-24
Accepted
2024-05-24 16:30:33
Documents
15
Period of Report
2024-05-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opgeninc_8k.htm   iXBRL 8-K 30269
2 EXHIBIT 99.1 opgeninc_ex99-1.htm EX-99.1 8531
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5386
  Complete submission text file 0001829126-24-003748.txt   223350

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE opgn-20240520.xsd EX-101.SCH 2991
5 XBRL LABEL FILE opgn-20240520_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE opgn-20240520_pre.xml EX-101.PRE 22343
18 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_8k_htm.xml XML 3645
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 24984876
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)